GlassScriptPhysician profile
James L Johnston
NPI 1316940174
$14,368.30
in general payments reported to CMS, 2019-2025
48 companies · $3,499 in 2025
The $3,499 reported for 2025 was more than what 92% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,434 · 2020: $663 · 2021: $601 · 2022: $1,184 · 2023: $2,510 · 2024: $2,477 · 2025: $3,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,486.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $2,724.99 | 2019-2021 | |
| Alcon Vision LLC | $2,603.98 | 2021-2025 | Clareon, Argos, Hydrus Microstent |
| Bausch & Lomb Americas INC. | $1,431.09 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $820.84 | 2022-2024 | Tyrvaya, Ryzumvi |
| New World Medical,INC. | $673.72 | 2021-2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Abbvie INC. | $589.27 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $408.09 | 2019-2025 | Cequa |
| Dompe US, INC. | $389.33 | 2019-2025 | Oxervate |
| Rayner Intraocular Lenses Limited | $383.82 | 2023-2025 | Rayone Emv, Rayone Aspheric, Rayone Spheric |
| Amgen INC. | $381.03 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $338.21 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $279.00 | 2025 | |
| Novo Nordisk INC | $272.59 | 2019-2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $249.37 | 2019-2020 | |
| Harrow Eye, LLC | $246.06 | 2024-2025 | Vevye, Iheezo |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.